Dr. Cohn on Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Video

Allen L. Cohn, MD, medical oncologist, Rocky Mountain Cancer Centers, discusses the use of neoadjuvant chemotherapy in the treatment of patients with locally advanced pancreatic cancer.

Allen L. Cohn, MD, medical oncologist, Rocky Mountain Cancer Centers, discusses the use of neoadjuvant chemotherapy in the treatment of patients with locally advanced pancreatic cancer.

Neoadjuvant chemotherapy is not a standard of care in patients with locally advanced pancreatic cancer, but it is becoming prevalent in those with borderline resectable disease, says Cohn. The goal of neoadjuvant chemotherapy is to shrink tumors, subsequently enabling a successful R0 resection and improved overall survival.

Several studies are now also looking at giving neoadjuvant chemotherapy and radiation followed by adjuvant chemotherapy in patients with locally advanced disease as an alternative approach. Recent data from investigators at the Mayo Clinic suggest that among patients who receive neoadjuvant chemotherapy, those whose CA-19-9 levels normalize and patients who complete the full course of treatment have improved survival approaching 60 months, concludes Cohn.

Related Videos
Kathryn Beckermann, MD, PhD
Eleonora Dondossola, PhD
William B. Pearse, MD
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, David M. Livingston, MD, Chair, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
Rachid Baz, MD, section head, Myeloma, Department of Malignant Hematology, Moffitt Cancer Center; co-director, Pentecost Family Myeloma Research Center
Harriet Kluger, MD, Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; director, Yale SPORE in Skin Cancer; vice chair, Translational Research, Internal Medicine; chief, Division of Skin and Kidney Cancer; associate cancer center director, Education, Training and Faculty Development; deputy section chief, Medical Oncology, Yale Cancer Center
Robert DeBernardo, MD, section head, Obstetrics and Gynecology, Women’s Health Institute, Cleveland Clinic
Jacob Shreve, MD, MS, hematology/oncology fellow, Mayo Clinic
Abhishek Tripathi, MD, genitourinary medical oncologist, City of Hope
Pooja Advani, MBBS, MD, Mayo Clinic